Cancer cachexia reduces the efficacy of immune checkpoint inhibitors in cancer patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cancer cachexia reduces the efficacy of immune checkpoint inhibitors in cancer patients

Published:2024-03-11 Issue:6 Volume:16 Page:5354-5369
ISSN:1945-4589
Container-title:Aging
language:en
Short-container-title:Aging

Author:

Yu Yean¹,Yan Li²,Huang Tianhui²,Wu Zhenfu³,Liu Juan⁴⁵

Affiliation:

1. Department of Nephrology, Wuhan Third Hospital, Tongren Hospital of Wuhan University, Wuhan, China

2. Department of Traditional Chinese Medicine, Wuhan Third Hospital, Tongren Hospital of Wuhan University, Wuhan, China

3. Department of Abdominal and Pelvic Medical Oncology, Huangshi Central Hospital, Affiliated Hospital of Hubei Polytechnic University, Huangshi, China

4. Department of Critical Care Medicine, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, China

5. Department of Critical Care Medicine, Affiliated Hospital of Hubei University of Chinese Medicine, Wuhan, China

Publisher

Impact Journals, LLC

Reference49 articles.

1. Hallmarks of cancer: the next generation.;Weinberg;Cell,2011

2. Recent advances of engineered oncolytic viruses-based combination therapy for liver cancer.;Liang;J Transl Med,2024

3. The blockade of immune checkpoints in cancer immunotherapy.;Pardoll;Nat Rev Cancer,2012

4. Cancer immunotherapy using checkpoint blockade.;Wolchok;Science,2018

5. Cancer immunoediting and resistance to T cell-based immunotherapy.;Smyth;Nat Rev Clin Oncol,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP